![](https://www.statnews.com/wp-content/uploads/2023/10/Lotte-768x432.jpg)
The Obesity Revolution
A new generation of obesity drugs is transforming patients’ lives, dividing medical experts, and spurring the biggest business battle in years. Known as incretin mimetics or GLP-1-based drugs, this medication class is seen as the first of a very long line that could have the medical and societal impact of blockbusters like Viagra, Lipitor, and Prozac. Like them, these weight-loss drugs have the potential to reshape the way we think of what it means to be sick and what it takes to be healthy.
Latest
![](https://www.statnews.com/wp-content/uploads/2023/10/Lotte-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/09/glp-1-shadow-pop-768x432.jpg)
GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?
![](https://www.statnews.com/wp-content/uploads/2023/09/FINAL-small-Svetlana-Mojsov-Marian-F.-Moratinos-x-STAT-768x432.jpg)
STAT Plus: The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she’s been edged out of the story
![](https://www.statnews.com/wp-content/uploads/2023/09/ObesityDrugTracker_blue_Illustration_MollyFerguson_091023.jpg-768x432.jpg)
STAT Plus: New obesity drugs are in the works trying to out-blockbuster Wegovy and Mounjaro
![](https://www.statnews.com/wp-content/uploads/2023/09/Curated-Card-Image-Obesity-Drug-Tracker-768x432.jpg)
STAT Plus: Here are the dozens of weight loss drugs in development to catch a booming market
![](https://www.statnews.com/wp-content/uploads/2022/06/GettyImages-1175677752-768x432.jpg)
STAT Plus: What do new weight loss drugs mean for the future of bariatric surgery?
![](https://www.statnews.com/wp-content/uploads/2023/08/FINAL-Final_Specialists-Scarcity_MarianF.Moratinos-768x432.jpg)
STAT Plus: Obesity specialists are scarce. Here’s how that’s starting to change
![](https://www.statnews.com/wp-content/uploads/2023/08/unnamed-1-768x432.jpeg)
STAT Plus: Alarmed by popularity of Ozempic and Wegovy, insurers wage multi-front battle
All Coverage
![](https://www.statnews.com/wp-content/uploads/2023/07/06-07-23_LONDON_STAT_75010-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/06/GettyImages-1482904507-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/05/GettyImages-1247409640-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/06/GLOBAL_BMI_COLLAGE_0606_v3-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/04/AD100147-2-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/03/WeGovy_Illustration_MollyFerguson_030823-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/01/FINAL-ART-Obese-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/03/0447_Why-BMI-STILL-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/03/Card-illo-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2023/01/AdobeStock_337865392-768x432.jpeg)
![](https://www.statnews.com/wp-content/uploads/2023/01/1-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2016/11/AP_653201735623-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2022/08/PHONE_SCALE_02-768x432.jpg)